Status:
RECRUITING
High- Versus Low-calcium Water for Bone Health
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Orthopedic Disorder
Calcium Metabolism Disorders
Eligibility:
All Genders
25-55 years
Phase:
NA
Brief Summary
The experimental study investigates which metabolic responses of calcium and parathyroid hormone are observable in blood and urine in a cohort of 41 healthy adults following a sequence of different ex...
Eligibility Criteria
Inclusion Criteria:
- Body mass index ≥ 18 and < 30
- Maintenance of diet and physical activity lifestyle throughout the duration of the study
- Acceptance of informed consent
Exclusion Criteria:
- Consumption of water with calcium > 150 mg/L
- Pregnancy (as established by self-declaration), breastfeeding, menopause
- Inability to follow the study protocol
- Cardiac, vascular, renal, and oncological disease
- Neuropsychiatric disease, developmental disorders
- Disease or past surgery affecting the gastrointestinal tract
- Drugs that interfere with bone (e.g. corticosteroids) or with fluid balance (e.g. diuretics)
Key Trial Info
Start Date :
March 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT05772364
Start Date
March 2 2023
End Date
May 31 2026
Last Update
May 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Ortopedico Galeazzi
Milan, Italy